| MASS Stock | | | USD 2.74 0.12 4.58% |
Founder
Andrew Bartfay is CoFounder Development of 908 Devices
| Address | 645 Summer Street, Boston, MA, United States, 02210 |
| Phone | 857 254 1500 |
| Web | https://908devices.com |
908 Devices Management Efficiency
The company has return on total asset
(ROA) of
(0.1556) % which means that it has lost $0.1556 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity
(ROE) of
(0.4) %, meaning that it created substantial loss on money invested by shareholders. 908 Devices' management efficiency ratios could be used to measure how well 908 Devices manages its routine affairs as well as how well it operates its assets and liabilities.
Return On Tangible Assets is likely to drop to -0.21 in 2024.
Return On Capital Employed is likely to drop to -0.25 in 2024. At this time, 908 Devices'
Net Tangible Assets are comparatively stable compared to the past year.
Non Currrent Assets Other is likely to gain to about 1.5
M in 2024, whereas
Non Current Assets Total are likely to drop slightly above 16.8
M in 2024.
908 Devices currently holds 5.95
M in liabilities with Debt to Equity
(D/E) ratio of 0.1, which may suggest the company is not taking enough advantage from borrowing. 908 Devices has a current ratio of 15.15, suggesting that it is
liquid enough and is able to pay its financial obligations when due. Note, when we think about 908 Devices' use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Found 1 records | FOUNDER Age |
| Douglas Unis | Monogram Orthopaedics Common | 55 |
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts. 908 Devices operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 177 people. 908 Devices (MASS) is traded on NASDAQ Exchange in USA. It is located in 645 Summer Street, Boston, MA, United States, 02210 and employs 230 people. 908 Devices is listed under Health Care Equipment & Supplies category by Fama And French industry classification.
Management Performance
908 Devices Leadership Team
Elected by the shareholders, the 908 Devices' board of directors comprises two types of representatives: 908 Devices inside directors who are chosen from within the company, and outside directors, selected externally and held independent of 908. The board's role is to monitor 908 Devices' management team and ensure that shareholders' interests are well served. 908 Devices' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, 908 Devices' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Kevin Knopp, CEO, CoFounder | |
| Joseph IV, CFO Treasurer | |
| Steve Araiza, CoFounder | |
| Scott Miller, Cofounder Engineering | |
| JD Esq, Chief Secretary | |
| Christopher Brown, Chief CoFounder | |
| Andrew Bartfay, CoFounder Development | |
| Trent Basarsky, VP Devel | |
| Michael Jobin, CoFounder Development | |
| Maura Fitzpatrick, VP Marketing | |
| Don Osmer, Vice Resources | |
| Barbara Russo, VP Communications | |
908 Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is 908 Devices a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for 908 Stock Analysis
When running 908 Devices' price analysis, check to
measure 908 Devices' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 908 Devices is operating at the current time. Most of 908 Devices' value examination focuses on studying past and present price action to
predict the probability of 908 Devices' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 908 Devices' price. Additionally, you may evaluate how the addition of 908 Devices to your portfolios can decrease your overall portfolio volatility.